Speaker Profile

M.D., FACP, CEO and Executive Director, Inova Schar Cancer Institute

Dr. Trump joined the Inova Schar Cancer Institute (ISCI) as its Chief Executive Officer on January 5, 2015. He most recently served as president and CEO of Roswell Park Cancer Institute (RPCI) in Buffalo, NY. Roswell Park Cancer Institute is one of the nation’s nationally designated cancer centers. Under Trump’s 13-year leadership, Roswell Park substantially expanded its patient care, research and education programs. Dr. Trump is a medical oncologist who specializes in the treatment of patients with genitourinary cancers, especially prostate and bladder cancer. He has received peer reviewed research funding from the National Cancer Institute, the Department of Defense and the American Cancer Society. Since his assuming the position of CEO, ISCI in 2015, he has recruited more the 30 cancer clinicians and scientists to develop ISCI program in drug discovery, biomarker development, clinical genomics and clinical cancer trials. ISCI established the first Molecular Tumor Board in the Spring of 2016.

Session Abstract – PMWC 2017 Silicon Valley

Session Synopsis: Health care systems that are implementing precision medicine programs face practical challenges: empowering physicians with genomic education; meaningful interpretation of molecular Dx test results; and patient access to drugs including through clinical trials. Three precision medicine leaders from large hospitals systems will discuss how they are addressing these challenges in this expert panel.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

View the top 3 talks from PMWC here (password: top-videos).